跳至主要内容
临床试验/CTRI/2025/03/081520
CTRI/2025/03/081520进行中(未招募)不适用

To assess potential of automated quantitative blood cell analyzer that combines innovative micro-nano technology and computer vision for blood analysis.

Epigeneres Biotech Pvt.Ltd1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2025年3月15日最近更新:

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
100
试验地点
1
主要终点
1.Assessment of potential of iMOST-L analyzer for the quantitative measurement of blood count (CBC) parameters.

研究概览

简要总结

Aim : To assess potential of automated quantitative blood cell analyzer that combines innovative micro-nano technology and computer vision for blood analysis.

Milestone to be achieved : To assess potential of iMOST-L analyzer for the quantitative measurement of complete blood count (CBC) parameters.

Study Design : 5 ml of blood sample will be collected from all eligible subjects for the study.

Objectives :

  1. To assess potential of iMOST-L analyzer for the quantitative measurement of complete blood count (CBC) parameters.

  2. To determine accuracy of the device by comparing data obtained from device with data obtained from standard blood testing method.

  3. To determine specificity and sensitivity of the iMOST-L analyzer by comparing results obtained from peripheral blood analysis with fingertip blood analysis.

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 90.00 Year(s)(—)
性别
All

入选标准

  • Inclusion criteria:
  • Age: 18-90 years, irrespective of clinical history
  • Subjects who are able to understand and willing to sign the informed consent form (ICF)
  • Subjects who are willing and able to comply with scheduled visit.

排除标准

  • Exclusion criteria:
  • Age less than 18 years.
  • Subject suffering from Immune thrombocytopenic purpura (ITP)
  • Subjects on cytotoxic drugs
  • Verified biohazard samples will be excluded.

结局指标

主要结局

1.Assessment of potential of iMOST-L analyzer for the quantitative measurement of blood count (CBC) parameters.

时间窗: Baseline

2.Accuracy of the device determined by comparing device generated data with standard blood testing method .

时间窗: Baseline

3.Specificity and sensitivity of the iMOST-L analyzer determined by comparing results obtained from peripheral blood and fingertip blood analysis .

时间窗: Baseline

次要结局

未报告次要终点

研究者

发起方
Epigeneres Biotech Pvt.Ltd
申办方类型
Other [Biotechnology Company ]
责任方
Principal Investigator
主要研究者

Dr Mugdha Ghag

Epigeneres Biotech Pvt.Ltd

研究点 (1)

Loading locations...

相似试验